Page last updated: 2024-10-29

indolepropanol phosphate and Thyroid Neoplasms

indolepropanol phosphate has been researched along with Thyroid Neoplasms in 1 studies

indolepropanol phosphate: binds specifically to the alpha subunit, but not to the beta subunit of tryptophan synthase
3-(indol-3-yl)propyl phosphate : An monoalkyl phosphate compound having an O-3-(indol-3-yl)propyl substituent.

Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Varinelli, L1
Caccia, D1
Volpi, CC1
Caccia, C1
De Bortoli, M1
Taverna, E1
Gualeni, AV1
Leoni, V1
Gloghini, A1
Manenti, G1
Bongarzone, I1

Other Studies

1 other study available for indolepropanol phosphate and Thyroid Neoplasms

ArticleYear
4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.
    Endocrine-related cancer, 2015, Volume: 22, Issue:5

    Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma; Carcinoma, Papillary; Cell Cycle; Cell P

2015